Related Experiment Video
Updated: Jan 24, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the
Cornelis Bisschop1, Thijs T Wind1, Christian U Blank2
1Department of Medical Oncology, University Medical Center Groningen, Groningen.
Abstract:
Toxicity of immune checkpoint inhibitors such as ipilimumab and nivolumab is likely associated with clinical efficacy. In this study, we aim to evaluate this association for pembrolizumab. To this end, data of 147 patients included in the Dutch cohort of the Pembrolizumab Expanded Access Program were collected. All data were collected prospectively. Patients with adverse events (AEs) at any time during therapy showed a higher chance of achieving disease control compared with patients without AEs (low-grade AEs vs. no AEs: odds ratio=12.8, P=0.0002, high-grade AEs vs. no AEs: odds ratio=38.5, P=0.0001) according to a multivariate logistic regression analysis. In addition, Cox regression analysis showed a lower risk of death (hazard ratio: 0.51, 95% confidence interval: 0.28-0.97) and disease progression (hazard ratio: 0.54, 95% confidence interval: 0.30-0.98) over time for patients with high-grade AEs at any time during therapy compared with patients without AEs during therapy. To correct for time dependency of occurrence of AEs, a pseudolandmark analysis at 6 months of therapy was performed. Although significance was lost (Wald test P>0.05), prolonged survival in 3 patients who stopped therapy within 6 months due to the occurrence of AEs was observed, suggesting the potential treatment benefit despite the premature ending of therapy. The occurrence of high-grade toxicity at any time during treatment was associated with higher objective response rates, progression-free survival, and overall survival. There remains a need to assess the predictive value of early occurring AEs on patient survival.
Insights
Immune checkpoint inhibitor toxicity, like that from pembrolizumab, correlates with better disease control and survival. High-grade adverse events (AEs) significantly improved outcomes, suggesting a link between toxicity and efficacy.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Immune checkpoint inhibitors (ICIs) like ipilimumab and nivolumab show toxicity linked to clinical efficacy.
- Pembrolizumab is an ICI used in cancer treatment.
Purpose of the Study:
- To evaluate the association between pembrolizumab-induced toxicity and clinical efficacy.
- To determine if adverse events (AEs) predict treatment outcomes in patients receiving pembrolizumab.
Main Methods:
- Prospective data collection from 147 patients in the Pembrolizumab Expanded Access Program.
- Multivariate logistic regression and Cox regression analyses were used.
- A pseudolandmark analysis at 6 months was performed to address time-dependent AEs.
Main Results:
- Patients experiencing any AEs showed a higher chance of disease control compared to those without AEs (low-grade OR=12.8, high-grade OR=38.5).
- High-grade AEs were associated with a reduced risk of death (HR=0.51) and disease progression (HR=0.54).
- Prolonged survival was observed in patients who stopped therapy early due to AEs, suggesting a potential benefit.
Conclusions:
- High-grade toxicity from pembrolizumab is associated with improved objective response rates, progression-free survival, and overall survival.
- The occurrence of AEs during treatment may serve as a predictive marker for patient survival.
- Further research is needed to validate the predictive value of early AEs on patient survival.
More Related Videos
09:38Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
08:24The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
Published on: August 25, 2023
Related Concept Videos
Predicting Reaction Outcomes
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...